Literature DB >> 8855756

Pemoline-induced autoimmune hepatitis.

M J Sterling1, M Kane, N D Grace.   

Abstract

We present a case of pemoline-induced autoimmune hepatitis in a 46-yr-old woman who received the drug for management of her multiple sclerosis. The autoimmune nature of the hepatitis is based on elevation of her anti-nuclear antibodies, anti-thyroid antibodies, IgA, and IgM globulins. These features of autoimmunity disappeared with normalization of her liver-associated enzymes and have remained negative for at least 6 months after completion of prednisone therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855756

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Drug-Induced Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Methylphenidate-induced autoimmune hepatitis.

Authors:  Jason J Lewis; Julia C Iezzoni; Carl L Berg
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

Review 4.  Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis.

Authors:  Helen Tremlett; Joel Oger
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

5.  A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis.

Authors:  Koji Harada; Yasuhiro Akai; Sachi Koyama; Yasuhide Ikenaka; Yoshihiko Saito
Journal:  Clin Rheumatol       Date:  2008-06-18       Impact factor: 2.980

Review 6.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 7.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.